Research Output per year
Research Output per year
Personal profile
Research interests
Dr. Cheng Jiang's research is focused on the cellular and molecular signaling mechanisms relevant to prostate and breast cancer chemoprevention.
Many of her publications deal with identification of herbal chemicals and novel selenium compounds targeting sex hormone signaling related to breast and prostate cancer.
Dr. Jiang has profound bilateral hearing loss and prefers email communications from her collaborators.
Fingerprint
Dive into the research topics where Cheng Jiang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
-
Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer
Zhang, J., Kim, S., Li, L., Kemp, C. J., Jiang, C. & Lü, J., May 1 2020, In : Prostate. 80, 7, p. 588-605 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice
Kim, S., Zhang, Y., Tang, S., Qin, C., Karelia, D., Sharma, A., Jiang, C. & Lu, J., Jun 15 2019, In : Prostate. 79, 9, p. 949-960 12 p.Research output: Contribution to journal › Article › peer-review
-
Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells
Wu, W., Karelia, D., Pramanik, K., Amin, S., Sharma, A., Jiang, C. & Lu, J., Aug 2018, In : Molecular Carcinogenesis. 57, 8, p. 1055-1066 12 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Role of p53-senescence induction in suppression of LNCaP prostate cancer growth by cardiotonic compound bufalin
Zhang, Y., Dong, Y., Melkus, M. W., Yin, S., Tang, S. N., Jiang, P., Pramanik, K., Wu, W., Kim, S., Ye, M., Hu, H., Lu, J. & Jiang, C., Nov 2018, In : Molecular cancer therapeutics. 17, 11, p. 2341-2352 12 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models
Wu, W., Tang, S. N., Zhang, Y., Puppala, M., Cooper, T. K., Xing, C., Jiang, C. & Lü, J., 2017, In : American Journal of Chinese Medicine. 45, 8, p. 1773-1792 20 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations